Ravago Americas says it and its subsidiaries are positioned to meet the challenge of materials demand related to COVID-19.
Orlando, Fla.-based Ravago's distribution units include Amco Polymers, Burcham International, Channel Prime Alliance, Entec Polymers, Genesis Polymers and Muehlstein; as well as its own chemicals and manufacturing units. In an April 13 news release, officials said that all of these businesses "are helping to meet the urgent demand for polymers and chemicals used in critical products for the diagnosis and treatment of COVID-19 for protection of those on the front lines."
Products using materials distributed by Ravago include test kits, diagnostic consumables, ventilator components and personal protection equipment (PPE), including face shields. Ravago's chemicals unit also is providing ingredients used in hand sanitizers and other critical products to help slow the spread of the virus.
Officials said that Ravago "is in constant contact" with suppliers, warehouses and logistics teams to manage the changing dynamics of the outbreak while addressing high demand for polymers and chemicals from key medical OEMs and contract manufacturers.
"Ravago has been a key supplier to the medical and packaging industries for decades and we are humbled to do our part to help combat this pandemic," CEO Jim Duffy said in the release.
"With our extensive network of distribution centers throughout North and South America, we are able to position essential products close to where they are needed for key medical customers to respond to intense market demand for diagnostic tests, medical devices and PPE as fast as possible," he added.
Ravago employs 7,000 worldwide and sells more than 12 billion pounds of resins and compounds per year. The firm's compounding and recycling facilities have more than 2 billion pounds of annual production capacity.